Abstract:The genome, whose stability is essential for survival, is incessantly exposed to internal and external stressors, which introduce an estimated 104 to 105 lesions, such as oxidation, in the nuclear genome of each mammalian cell each day. A delicate homeostatic balance between the generation and repair of DNA lesions maintains genomic stability. To initiate transcription, DNA strands unwind to form a transcription bubble and provide a template for the RNA polymerase II (RNAPII) complex to synthesize nascent RNA. The process generates DNA supercoils and introduces torsional stress. To enable RNAPII processing, the supercoils are released by topoisomerases by introducing strand breaks, including double-stranded breaks (DSBs). Thus, DSBs are intrinsic genomic features of gene expression. The breaks are quickly repaired upon processing of the transcription. DNA lesions and damaged proteins involved in transcription could impede the integrity and efficiency of RNAPII processing. The impediment, which is referred to as transcription stress, not only could lead to the generation of aberrant RNA species but also the accumulation of DSBs. The latter is particularly the case when topoisomerase processing and/or the repair mechanisms are compromised. The DSBs activate the DNA damage response (DDR) pathways to repair the damaged DNA and/or impose cell cycle arrest and cell death. In addition, the release of DSBs into the cytosol activates the cytosolic DNA-sensing proteins (CDSPs), which along with the nuclear DDR pathways induce the expression of senescence-associated secretory phenotype (SASP), cell cycle arrest, senescence, cell death, inflammation, and aging. The primary stimulus in hereditary cardiomyopathies is a mutation(s) in genes encoding the protein constituents of cardiac myocytes; however, the phenotype is the consequence of intertwined complex interactions among numerous stressors and the causal mutation(s). Increased internal DNA stressors, such as oxidation, alkylation, and cross-linking, are expected to be common in pathological conditions, including in hereditary cardiomyopathies. In addition, dysregulation of gene expression also imposes transcriptional stress and collectively with other stressors provokes the generation of DSBs. In addition, the depletion of nicotinamide adenine dinucleotide (NAD), which occurs in pathological conditions, impairs the repair mechanism and further facilitates the accumulation of DSBs. Because DSBs activate the DDR pathways, they are expected to contribute to the pathogenesis of cardiomyopathies. Thus, interventions to reduce the generation of DSBs, enhance their repair, and block the deleterious DDR pathways would be expected to impart salubrious effects not only in pathological states, as in hereditary cardiomyopathies but also aging.

Reduction of double-strand DNA break repair exacerbates vascular aging

DNA Damage: A Main Determinant of Vascular Aging

DNA damage response, a double-edged sword for vascular aging

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

Local endothelial DNA repair deficiency causes aging-resembling endothelial-specific dysfunction

DNA Damage-related Vascular Dysfunction: Pathways and Interventions

Local endothelial dna repair defect causes aging-resembling endothelial-specific dysfunction.

Oxidative DNA damage promotes vascular aging associated with changes in extracellular matrix-regulating proteins.

Aging Neurovascular Unit and Potential Role of DNA Damage and Repair in Combating Vascular and Neurodegenerative Disorders

The role of senescence, telomere dysfunction and shelterin in vascular aging

Decoding vascular aging: implications for atherosclerosis progression and clinical intervention

Targeting vascular senescence in cardiovascular disease with aging

Restoring mitochondrial DNA copy number preserves mitochondrial function and delays vascular aging in mice

Premature aging induced by radiation exhibits pro-atherosclerotic effects mediated by epigenetic activation of CD44 expression

Anthracycline chemotherapy‐mediated vascular dysfunction as a model of accelerated vascular aging

Causes and consequences of DNA double-stranded breaks in cardiovascular disease

Cellular Senescence Contributes to Large Elastic Artery Stiffening and Endothelial Dysfunction With Aging: Amelioration With Senolytic Treatment

DNA damage—how and why we age?

The Implications of Aging on Vascular Health

Molecular Mechanisms of Vascular Health: Insights From Vascular Aging and Calcification

Model Systems to Study the Mechanism of Vascular Aging